This fund shows that industry expertise can help you make a lot of money in the stock market

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 58 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 97%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

The managers of the Janus Henderson Global Life Sciences Fund have direct experience to help them separate promising innovators from flashes in the pan.

Investors and the financial media have been fixated on exchange-traded funds for decades. The inexpensive passive tracking of stock indexes often has led to a performance that traditional active money managers have been hard-pressed to match. But there are always exceptions, and the healthcare sector is one of them.

All investment returns in this article are net of expenses and assume the reinvestment of dividends and capital-gain distributions. Annual expenses for the Janus Henderson Global Life Sciences Fund total 0.98% of assets under management. The expense ratio for SPY is 0.095%; it is 0.35% for XBI. The rest of the fund is roughly split between pharmaceutical companies and providers of healthcare devices and services.

He also pointed to Intuitive Surgical Inc. ISRG, +0.08%, which is employing AI and algorithms to help doctors predict the outcomes of surgeries. “They can make a good surgeon even better, by tailoring the approach to the best outcomes, whether it be prostate removal or orthopedic procedures, Lyons said.

There are three companies whose stocks are held by the fund that Lyons believes “can really help with this condition over time.” He also named Akero Therapeutics Inc. AKRO, -4.78% and 89bio Inc. ETNB, -4.31%, which are both developing injectable therapies to remove liver scarring, which “will be important therapies to add on to the Madrigal therapy, to help patients avoid losing their livers over time.”

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 3. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인